
IndraLab
Statements
Calcium(2+) inhibits KCNK2. 3 / 3
|
3
reach
"Since Ca store-active drugs were reported to block TREK-1 channels (18,19), it is intriguing to investigate whether bepridil can regulate the TREK-1 activity at a clinically therapeutic concentration.Furthermore, BL1249 has previously been validated to be specifically active in the TREK-1 channel, not only in heterologous expression systems but also in primary cells (20,21), which act on a gating mechanism involving a site located below the selectivity filter and the C-type gate (2)."